Skip to main content
. 2017 Sep;10(6):311–321.

Table 1.

Demographics of the Study Populationa,b

Patient characteristic Menopausal symptoms
(N = 383)
Diabetesc
(N = 1292)
Disorders of lipid metabolism
(N = 2398)
Headache
(N = 806)
Cataract
(N = 158)
Glaucoma
(N = 143)
Essential hypertension
(N = 3313)
Influenza
(N = 515)
Age, yrs, mean (SD) 53.6 (5.2) 55.8 (5.9) 56.1 (5.8) 52.8 (5.6) 59.6 (5.4) 57.0 (5.7) 55.3 (6.0) 54.3 (5.8)
 45–50, % 30.3 24.0 21.3 41.2 8.9 17.5 26.5 30.7
 51–55, % 37.1 22.2 22.7 26.4 11.4 21.7 23.7 27.0
 56–60, % 20.4 27.2 28.6 20.7 21.5 28.0 25.1 23.7
 61–65, % 12.3 26.6 27.4 11.7 58.2 32.9 24.6 18.6
Race/ethnicity, %
 White 68.7 31.9 46.1 52.9 53.8 42.7 37.5 56.9
 Black 12.3 25.7 19.7 16.0 23.4 28.0 29.6 11.3
 Asian 3.1 6.8 7.7 6.0 7.6 9.8 7.3 6.2
 Hispanic 14.9 32.4 24.5 23.9 12.7 18.9 23.5 23.1
 Other 1 3.2 2 1.2 2.5 0.7 2.0 2.5
Insured, % 82.2 72.5 77.7 79.7 86.1 76.2 73.6 73.6
Education, mean, yrs (SD) 13.9 (2.7) 11.5 (4.0) 12.3 (3.8) 13.0 (3.5) 13.2 (3.6) 12.8 (3.9) 12.2 (3.7) 13.1 (3.7)
 Less than high school, % 6 30.7 22.9 17.9 19.0 20.3 23.4 15.3
 GED/high school diploma, % 48 46.4 46.2 41.6 36.1 37.8 47.9 43.9
 Bachelor's, % 23 11.2 15.4 19.5 25.9 13.3 14.4 22.1
 Master's or above, % 23 11.8 15.6 21.5 19.0 28.7 14.4 19.0
Income, US$, mean (SD) 37,804 (36,401) 23,314 (27,235) 28,296 (31,691) 32,754 (34,409) 34,839 (37,652) 29,068 (32,387) 26,370 (28,242) 32,929 (32,549)
 Relative to federal poverty level, %
 <100 11 24.7 20.4 16.3 22.8 25.9 20.6 12.8
 100 to <125 2.6 7.2 5.2 4.2 5.1 5.6 6.5 2.9
 125 to <200 11.5 16.6 15.3 15.3 9.5 14.0 16.4 16.9
 200 to <400 26.9 29.1 28.0 30.6 21.5 23.8 28.9 28.0
 ≥400 48 22.4 31.1 33.6 41.1 30.8 27.6 39.4
COPD and bronchiectasis
(N = 667)
Asthma
(N = 820)
Esophageal disorders
(N = 786)
UTIs
(N = 453)
Osteoarthritis
(N = 884)
Osteoporosis
(N = 1051)
Anxiety disorders
(N = 1170)
Mood disorders
(N = 1431)
Age, yrs, mean (SD) 55.0 (5.8) 54.4 (5.7) 55.2 (6.0) 53.9 (6.0) 56.6 (5.6) 56.8 (5.6) 54.0 (5.8) 53.9 (5.6)
 45–50, % 26.5 30.7 27.2 34.7 18.4 17.3 32.8 32.0
 51–55, % 25.6 25.9 22.5 23.6 22.5 21.6 28.0 29.3
 56–60, % 27.4 25.7 27.0 26.3 28.2 28.8 22.5 24.0
 61–65, % 20.4 17.7 23.3 15.5 30.9 32.3 16.7 14.7
Race/ethnicity, %
 White 59.4 49.6 57.4 56.5 57.5 57.8 62.1 58.8
 Black 16.9 19.0 21.8 14.1 19.5 17.0 12.1 15.2
 Asian 1.8 6.1 3.4 3.1 3.1 5.0 2.6 3.1
 Hispanic 18.3 21.1 15.0 24.1 17.2 17.7 20.9 20.5
 Other 3.6 4.1 2.4 2.2 2.8 2.5 2.4 2.4
Insured, % 77.2 78.5 86.0 79.7 78.7 80.1 77.6 77.4
Education, mean (SD), yrs 12.9 (3.0) 12.9 (3.3) 12.7 (3.1) 12.9 (4.0) 13.2 (3.1) 13.2 (3.2) 13.1 (3.2) 12.7 (3.3)
 Less than high school, % 15.9 20.7 19.7 18.8 14.6 14.7 16.7 20.0
 GED/high school diploma, % 51.0 44.8 49.0 43.0 47.4 45.1 46.4 47.9
 Bachelor's, % 18.1 16.8 13.1 19.2 18.8 20.4 19.0 15.9
 Master's or above, % 15.4 17.9 18.6 19.2 19.5 20.0 18.0 16.3
Income, US$, mean (SD) 26,702 (28,170) 27,775 (32,983) 29,361 (33,727) 32,756 (33,132) 29,578 (34,147) 30,564 (34,117) 31,056 (34,631) 27,378 (30,950)
 Relative to federal poverty level, %
 <100 21.4 26.0 25.6 14.1 19.7 18.1 21.4 27.1
 100 to <125 5.8 4.9 5.7 4.2 4.8 4.4 5.0 5.2
 125 to <200 15.3 16.1 12.1 14.1 15.4 15.9 14.5 13.3
 200 to <400 29.1 25.0 25.1 29.8 27.0 26.4 26.8 26.6
 ≥400 28.3 28.0 31.6 37.7 33.1 35.3 32.2 27.9

NOTE: The study included women aged 45 to 65 years who had not had a hysterectomy and had menopausal symptoms or any of 15 comparator conditions and participated in the 2010, 2011, and/or 2012 MEPS-HC (descriptive statistics, pooled).

a

Data shown here are for women who were included in the modeled data analysis; some women who contributed direct cost data (see Appendix Table at www.AHDBonline.com) were excluded from the analysis if any of the covariate data were missing.

b

Percentages may not total 100 because of rounding.

c

Diabetes with/without complications, combined.

COPD indicates chronic obstructive pulmonary disease; GED, General Educational Development; MEPS-HC, Medical Expenditure Panel Survey Household Component; SD, standard deviation; UTIs, urinary tract infections.